86 related articles for article (PubMed ID: 27076170)
1. Development of Antibody-Based Vaccines Targeting the Tumor Vasculature.
Zhuang X; Bicknell R
Methods Mol Biol; 2016; 1403():839-49. PubMed ID: 27076170
[TBL] [Abstract][Full Text] [Related]
2. Cancer vaccines: an update with special focus on ganglioside antigens.
Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
[TBL] [Abstract][Full Text] [Related]
3. Vaccination against tumor neovascularization: Promise and reality.
Rafii S
Cancer Cell; 2002 Dec; 2(6):429-31. PubMed ID: 12498709
[TBL] [Abstract][Full Text] [Related]
4. SANTAVAC ™: A Novel Universal Antigen Composition for Developing Cancer Vaccines.
Lokhov PG; Balashova EE
Recent Pat Biotechnol; 2017; 11(1):32-41. PubMed ID: 27903220
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic vaccination targeting the tumour vasculature.
Olsson AK
Biochem Soc Trans; 2014 Dec; 42(6):1653-7. PubMed ID: 25399585
[TBL] [Abstract][Full Text] [Related]
6. Immunity against tumor angiogenesis induced by a fusion vaccine with murine beta-defensin 2 and mFlk-1.
Wang YS; Wang GQ; Wen YJ; Wang L; Chen XC; Chen P; Kan B; Li J; Huang C; Lu Y; Zhou Q; Xu N; Li D; Fan LY; Yi T; Wu HB; Wei YQ
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6779-87. PubMed ID: 18006780
[TBL] [Abstract][Full Text] [Related]
7. Targeting intracellular oncoproteins with antibody therapy or vaccination.
Guo K; Li J; Tang JP; Tan CP; Hong CW; Al-Aidaroos AQ; Varghese L; Huang C; Zeng Q
Sci Transl Med; 2011 Sep; 3(99):99ra85. PubMed ID: 21900592
[TBL] [Abstract][Full Text] [Related]
8. Enhancing efficacy of anticancer vaccines by targeted delivery to tumor-draining lymph nodes.
Jeanbart L; Ballester M; de Titta A; Corthésy P; Romero P; Hubbell JA; Swartz MA
Cancer Immunol Res; 2014 May; 2(5):436-47. PubMed ID: 24795356
[TBL] [Abstract][Full Text] [Related]
9. The anticancer efficiency of the xenogeneic vaccine and the indication for its use.
Symchych TV; Fedosova NI; Karaman OM; Yevstratieva LM; Lisovenko HS; Voyejkova IM; Potebnia HP
Exp Oncol; 2014 Jun; 36(2):79-84. PubMed ID: 24980760
[TBL] [Abstract][Full Text] [Related]
10. A Fixed Human Umbilical Vein Endothelial Cell Vaccine With 2 Tandem Repeats of Microbial HSP70 Peptide Epitope 407-426 As Adjuvant for Therapy of Hepatoma in Mice.
Xu M; Zhou L; Zhang Y; Xie Z; Zhang J; Guo L; Wang C; Yang X
J Immunother; 2015 Sep; 38(7):276-84. PubMed ID: 26261891
[TBL] [Abstract][Full Text] [Related]
11. Universal cancer vaccine: an update on the design of cancer vaccines generated from endothelial cells.
Lokhov PG; Balashova EE
Hum Vaccin Immunother; 2013 Jul; 9(7):1549-52. PubMed ID: 23571178
[TBL] [Abstract][Full Text] [Related]
12. Development of optimized cryptic peptides for immunotherapy.
Menez-Jamet J; Kosmatopoulos K
IDrugs; 2009 Feb; 12(2):98-102. PubMed ID: 19204883
[TBL] [Abstract][Full Text] [Related]
13. Vaccination against angiogenesis-associated antigens: a novel cancer immunotherapy strategy.
Li Y; Bohlen P; Hicklin DJ
Curr Mol Med; 2003 Dec; 3(8):773-9. PubMed ID: 14682497
[TBL] [Abstract][Full Text] [Related]
14. A murine model for antibody-directed targeting of vascular endothelial cells in solid tumors.
Burrows FJ; Watanabe Y; Thorpe PE
Cancer Res; 1992 Nov; 52(21):5954-62. PubMed ID: 1394221
[TBL] [Abstract][Full Text] [Related]
15. The case for polyvalent cancer vaccines that induce antibodies.
Ragupathi G; Livingston P
Expert Rev Vaccines; 2002 Aug; 1(2):193-206. PubMed ID: 12901558
[TBL] [Abstract][Full Text] [Related]
16. Combination of Photodynamic Therapy and Specific Immunotherapy Efficiently Eradicates Established Tumors.
Kleinovink JW; van Driel PB; Snoeks TJ; Prokopi N; Fransen MF; Cruz LJ; Mezzanotte L; Chan A; Löwik CW; Ossendorp F
Clin Cancer Res; 2016 Mar; 22(6):1459-68. PubMed ID: 26546617
[TBL] [Abstract][Full Text] [Related]
17. VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases.
Rad FH; Le Buanec H; Paturance S; Larcier P; Genne P; Ryffel B; Bensussan A; Bizzini B; Gallo RC; Zagury D; Uzan G
Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2837-42. PubMed ID: 17301234
[TBL] [Abstract][Full Text] [Related]
18. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
LaTemple DC; Abrams JT; Zhang SY; Galili U
Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
[TBL] [Abstract][Full Text] [Related]
19. Comparison of vaccine-induced effector CD8 T cell responses directed against self- and non-self-tumor antigens: implications for cancer immunotherapy.
Pedersen SR; Sørensen MR; Buus S; Christensen JP; Thomsen AR
J Immunol; 2013 Oct; 191(7):3955-67. PubMed ID: 24018273
[TBL] [Abstract][Full Text] [Related]
20. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
Pan JP; Weng YS; Wu QQ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
